Evolent Health, Inc. (EVH)
NYSE: EVH · Real-Time Price · USD
4.620
-0.210 (-4.35%)
Nov 17, 2026, 4:00 PM EST - Market closed

Evolent Health Balance Sheet

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
148.26151.86104.2192.83188.2266.28
Cash & Short-Term Investments
148.26151.86104.2192.83188.2266.28
Cash Growth
27.09%45.73%-45.96%2.46%-29.32%-16.53%
Accounts Receivable
442.77309.86414.68446.75254.68130.6
Receivables
442.77309.86414.68446.75254.68130.6
Prepaid Expenses
19.5718.5228.9430.3320.6851.39
Restricted Cash
6.5326.1359.313.7714.4975.69
Total Current Assets
617.12506.37607.12683.67478.05523.96
Property, Plant & Equipment
4.477.3610.5919.2863.260.37
Long-Term Investments
8.678.978.594.94.485.46
Goodwill
694.42694.481,1371,117722.77426.3
Other Intangible Assets
619.77662.74748.86822.91516.48350.98
Long-Term Accounts Receivable
-----4.88
Long-Term Deferred Tax Assets
-21.51--
Long-Term Deferred Charges
14.6713.5413.3812.1217.4632.62
Other Long-Term Assets
3.043.7817.0719.8914.8414.89
Total Assets
1,9621,8992,5442,6801,8171,419

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
37.8459.7896.0348.2557.1796.08
Accrued Expenses
73.87116.74100.08206.23163.66159.1
Current Portion of Long-Term Debt
--171.47---
Current Portion of Leases
1.3215.3426.729.747.127.07
Current Unearned Revenue
0.821.22.515.985.7611.94
Other Current Liabilities
376.08192.2318.71404.05199.73171.29
Total Current Liabilities
489.94385.26715.5674.24433.44445.49
Long-Term Debt
969.48970.54490.52597.05412.99215.68
Long-Term Leases
2.253.8224.9738.0156.0157.72
Long-Term Unearned Revenue
-0.11-1.172.534.44
Long-Term Deferred Tax Liabilities
10.647.5110.913.314.741.4
Other Long-Term Liabilities
117116.81111.09110.448.161.09
Total Liabilities
1,5891,4841,3531,434957.88725.83

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
1.181.181.171.151.020.91
Additional Paid-In Capital
1,8101,7931,8041,8081,4871,341
Retained Earnings
-1,394-1,315-780.82-719.19-606.15-626.78
Treasury Stock
-40.31-61.43-21.12-21.12-21.12-21.12
Comprehensive Income & Other
-3.93-2.62-1.75-1.26-1.18-0.36
Total Common Equity
372.85415.191,0011,068859.42693.63
Shareholders' Equity
372.85415.191,1911,246859.42693.63
Total Liabilities & Equity
1,9621,8992,5442,6801,8171,419

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
973.05989.7713.67644.8476.12280.47
Net Cash (Debt)
-824.8-837.84-609.47-451.97-287.92-14.19
Net Cash Growth
------
Net Cash Per Share
-7.35-7.34-5.31-4.06-3.07-0.16
Filing Date Shares Outstanding
113.11111.64115.05113.89109.5189.29
Total Common Shares Outstanding
113.1111.63115.04113.8999.9689.22
Working Capital
127.18121.11-108.389.4344.6178.47
Book Value Per Share
3.303.728.709.388.607.77
Tangible Book Value
-941.34-942.03-884.92-871.75-379.84-83.65
Tangible Book Value Per Share
-8.32-8.44-7.69-7.65-3.80-0.94
Machinery
15.7916.9915.7222.834.3125.55
Leasehold Improvements
0.821.441.481.0514.9315.33
SEC Filings: 10-K · 10-Q